These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36199185)

  • 21. Polo-like kinase 1 inactivation following mitotic DNA damaging treatments is independent of ataxia telangiectasia mutated kinase.
    Yuan JH; Feng Y; Fisher RH; Maloid S; Longo DL; Ferris DK
    Mol Cancer Res; 2004 Jul; 2(7):417-26. PubMed ID: 15280449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel EGFR-TK inhibitor EKB-569 inhibits hepatocellular carcinoma cell proliferation by AKT and MAPK pathways.
    Kim H; Lim HY
    J Korean Med Sci; 2011 Dec; 26(12):1563-8. PubMed ID: 22147992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of Beclin 1 in IR-induced crosstalk between autophagy and G2/M cell cycle arrest.
    Liang N; Liu X; Zhang S; Sun H
    Cell Signal; 2019 Oct; 62():109353. PubMed ID: 31260798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polo-like kinase 1 inhibition diminishes acquired resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer with T790M mutations.
    Wang Y; Singh R; Wang L; Nilsson M; Goonatilake R; Tong P; Li L; Giri U; Villalobos P; Mino B; Rodriguez-Canales J; Wistuba I; Wang J; Heymach JV; Johnson FM
    Oncotarget; 2016 Jul; 7(30):47998-48010. PubMed ID: 27384992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmaceutically inhibiting polo-like kinase 1 exerts a broad anti-tumour activity in retinoblastoma cell lines.
    Schwermer M; Dreesmann S; Eggert A; Althoff K; Steenpass L; Schramm A; Schulte JH; Temming P
    Clin Exp Ophthalmol; 2017 Apr; 45(3):288-296. PubMed ID: 27647547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knockdown of annexin A5 restores gefitinib sensitivity by promoting G2/M cell cycle arrest.
    Zhou J; Chang M; Li J; Fang T; Hu J; Bai C
    Respir Res; 2018 May; 19(1):96. PubMed ID: 29784046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
    Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C
    Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Could HBx protein expression affect signal pathway inhibition by gefitinib or selumetinib, a MEK inhibitor, in hepatocellular carcinoma cell lines?
    Park YK; Kim KM; Lee YJ; Kim KH; Lee SG; Lee D; Shim JH; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    J Korean Med Sci; 2011 Feb; 26(2):214-21. PubMed ID: 21286012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bortezomib induces G2-M arrest in human colon cancer cells through ROS-inducible phosphorylation of ATM-CHK1.
    Hong YS; Hong SW; Kim SM; Jin DH; Shin JS; Yoon DH; Kim KP; Lee JL; Heo DS; Lee JS; Kim TW
    Int J Oncol; 2012 Jul; 41(1):76-82. PubMed ID: 22552540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DHMMF, a natural flavonoid from Resina Draconis, inhibits hepatocellular carcinoma progression via inducing apoptosis and G2/M phase arrest mediated by DNA damage-driven upregulation of p21.
    Tian Y; Wang L; Chen X; Zhao Y; Yang A; Huang H; Ouyang L; Pang D; Xie J; Liu D; Tu P; Li J; Hu Z
    Biochem Pharmacol; 2023 May; 211():115518. PubMed ID: 36966937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CXCR4 promotes gefitinib resistance of Huh7 cells by activating the c-Met signaling pathway.
    Zhao D; Yang Z; Chen C; Zhang Z; Yu Y; Li Z
    FEBS Open Bio; 2021 Nov; 11(11):3115-3125. PubMed ID: 34555268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RO3280: A Novel PLK1 Inhibitor, Suppressed the Proliferation of MCF-7 Breast Cancer Cells Through the Induction of Cell Cycle Arrest at G2/M Point.
    Ergul M; Bakar-Ates F
    Anticancer Agents Med Chem; 2019; 19(15):1846-1854. PubMed ID: 31244432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PLK1 (polo like kinase 1)-dependent autophagy facilitates gefitinib-induced hepatotoxicity by degrading COX6A1 (cytochrome c oxidase subunit 6A1).
    Luo P; Yan H; Du J; Chen X; Shao J; Zhang Y; Xu Z; Jin Y; Lin N; Yang B; He Q
    Autophagy; 2021 Oct; 17(10):3221-3237. PubMed ID: 33315519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arenobufagin intercalates with DNA leading to G2 cell cycle arrest via ATM/ATR pathway.
    Deng LJ; Peng QL; Wang LH; Xu J; Liu JS; Li YJ; Zhuo ZJ; Bai LL; Hu LP; Chen WM; Ye WC; Zhang DM
    Oncotarget; 2015 Oct; 6(33):34258-75. PubMed ID: 26485758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. STK39 is a novel kinase contributing to the progression of hepatocellular carcinoma by the PLK1/ERK signaling pathway.
    Zhang C; Wang X; Fang D; Xu P; Mo X; Hu C; Abdelatty A; Wang M; Xu H; Sun Q; Zhou G; She J; Xia J; Hui KM; Xia H
    Theranostics; 2021; 11(5):2108-2122. PubMed ID: 33500714
    [No Abstract]   [Full Text] [Related]  

  • 36. 4-Hydroxynonenal induces G2/M phase cell cycle arrest by activation of the ataxia telangiectasia mutated and Rad3-related protein (ATR)/checkpoint kinase 1 (Chk1) signaling pathway.
    Chaudhary P; Sharma R; Sahu M; Vishwanatha JK; Awasthi S; Awasthi YC
    J Biol Chem; 2013 Jul; 288(28):20532-46. PubMed ID: 23733185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ovatodiolide isolated from Anisomeles indica induces cell cycle G2/M arrest and apoptosis via a ROS-dependent ATM/ATR signaling pathways.
    Yu CY; Jerry Teng CL; Hung PS; Cheng CC; Hsu SL; Hwang GY; Tzeng YM
    Eur J Pharmacol; 2018 Jan; 819():16-29. PubMed ID: 28986085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors.
    Zhang M; Singh R; Peng S; Mazumdar T; Sambandam V; Shen L; Tong P; Li L; Kalu NN; Pickering CR; Frederick M; Myers JN; Wang J; Johnson FM
    Cancer Lett; 2017 Apr; 392():71-82. PubMed ID: 28126323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small molecule inhibition of polo-like kinase 1 by volasertib (BI 6727) causes significant melanoma growth delay and regression in vivo.
    Cholewa BD; Ndiaye MA; Huang W; Liu X; Ahmad N
    Cancer Lett; 2017 Jan; 385():179-187. PubMed ID: 27793694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. UCN-01 induces S and G2/M cell cycle arrest through the p53/p21(waf1) or CHK2/CDC25C pathways and can suppress invasion in human hepatoma cell lines.
    Wu G; Lin N; Xu L; Liu B; Feitelson MA
    BMC Cancer; 2013 Mar; 13():167. PubMed ID: 23537372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.